Table 2.
The demographic and clinical properties of the enrolled subjects for RNA-sequencing (n = 20).
| Variable | All subject (n = 20) | Healthy (n = 5) | CHB (n = 5) | Cirrhosis (n = 5) | HCC (n = 5) | P value |
|---|---|---|---|---|---|---|
| Sex | 0.895 | |||||
| Male | 11 (55%) | 3 (60%) | 2 (40%) | 3 (60%) | 3 (60%) | |
| Female | 9 (45%) | 2 (40%) | 3 (60%) | 2 (40%) | 2 (40%) | |
| Age | 48.85 ± 11.88 | 44.2 ± 6.22 | 44.4 ± 17.81 | 51.60 ± 6.34 | 57.80 ± 5.63 | 0.157 |
| BMI | 27.15 ± 4.91 | 25.38 ± 4.14 | 25.62 ± 7.58 | 31.20 ± 2.77 | 26.40 ± 2.06 | 0.202 |
| ALT (U/L) | 71.80 ± 48.55 | 25.40 ± 2.70 | 27.02 ± 4.84 | 122.04 ± 14.66 | 58.80 ± 13.88 | <0.001 |
| AST (U/L) | 78.50 ± 55.14 | 26.02 ± 3.53 | 28.20 ± 6.76 | 140.40 ± 21.68 | 68.01 ± 12.02 | <0.001 |
| HBeAg + ve | 6 (30%) | 0 (0%) | 0 (0%) | 3 (60%) | 3 (60%) | 0.033 |
| Viral load log10 (Copies/mL) | (Median: 55331 Range: 2647–9560679) |
— | (Median: 5123 Range: 2647–9691) |
(Median: 59618 Range: 13200–102180) |
(Median: 5051258 Range: 623776–9560679) |
0.02 |